Medication

Millennials’ love affair with pets drives investment opportunity

What’s in stock for telehealth investments following the pandemic-led surge

Why India is poised to lead in post-pandemic growth

Will vaccines give a shot in the arm to pharmaceutical stocks?

AstraZeneca runs into ‘meaningful’ investor revolt over CEO pay

Kentucky Derby horses running without anti-bleeding drug Lasix under new rule

Johnson & Johnson beats estimates, reports $100-million in quarterly COVID-19 vaccine sales

Johnson & Johnson and three other pharma firms face California trial over claims they fueled opioid epidemic

‘Sicker and younger’: Toronto ICU copes with pressure during third wave of pandemic

Bausch Health selling stake in Egypt’s Amoun for $740-million

Pfizer to reportedly use mRNA technology behind COVID-19 shot to develop other vaccines

EU regulators team up with U.S. and U.K. on pharmaceutical mergers

Bausch Health names Sam Eldessouky as next CFO

B.C.’s Eupraxia Pharmaceuticals sees lacklustre trading debut

Canada’s missed shots: How Ottawa’s COVID-19 vaccine promises were out of step with reality

B.C. startup Eupraxia attempting rare TSX-only biotech IPO, raising hopes for revival of issues on senior Canadian exchange

Bausch Health shareholder pushes for completion of eye-care spinoff by end of 2021

Eli Lilly CFO resigns after probe finds ‘inappropriate communication’ with employees

Merck CEO Kenneth Frazier stepping down at the end of June

GSK forecasts dip in profit but says plan to split business still on track

Pfizer forecasts about $15-billion of COVID-19 vaccine sales in 2021

Bayer and Rentschler agrees to help CureVac manufacture its COVID-19 vaccine

McKinsey is open to settlement regarding opioid work in the U.S. and Canada

EU warns pharmaceuticals to honour COVID-19 vaccine delivery commitments

Johnson & Johnson expects to share COVID-19 vaccine data next week

Vancouver’s Khosrowshahi family to launch US$400-million pharma IPO, capitalizing on biotech craze

Shares in B.C.’s Aurinia jump more than 25 per cent on FDA approval to sell lupus drug

Investors sue Bayer over stock’s slump in wake of Roundup litigation

Investors flock to Canadian device maker Sernova hoping to transform how diabetes is treated

Bausch Health expects 2020 revenue to exceed previous guidance

Merck signs $356-million U.S. supply deal for experimental COVID-19 treatment